The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain
Article Abstract:
A study of the efficacy of lower doses of COX, -2 selective inhibitor parecoxib sodium for intravenous (IV) or intramuscular (IM) administration in postoperative dental pain is presented. The results show that parecoxib 20 mg IM is an effective and rapidly acting analgesic dose in patients who have undergone dental surgery and is a useful alternative to the higher 40 mg IV/IM dose or a 30 mg IV/IM dose of ketorolac in patients undergoing dental surgery.
Publication Name: Journal of the American Dental Association
Subject: Health
ISSN: 0002-8177
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
The optimal analgesic dose of rofecoxib: overview of six randomized controlled trials
Article Abstract:
A single dose of 50 milligrams of rofecoxib is effective in treating postoperative pain following dental surgery. This was the conclusion of researchers who evaluated dosages ranging from 7.5 milligrams to 500 milligrams. Rofecoxib belongs to a class of drugs called COX-2 inhibitors.
Publication Name: Journal of the American Dental Association
Subject: Health
ISSN: 0002-8177
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
The use of COX-2 inhibitors for acute dental pain: a second look
Article Abstract:
Cyclo-oxygenase-2 inhibitors (COX-2) have been prescribed as first-line agents for the treatment of dental pain. However, literature shows its adverse reactions tend to cause cardiovascular diseases. A reappraisal on the usage of these drugs is recommended.
Publication Name: Journal of the American Dental Association
Subject: Health
ISSN: 0002-8177
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The Lancaster experience of 2.0 to 2.5 mg/kg intramuscular ketamine for pediatric sedation: 501 cases and analysis
- Abstracts: Effects of tibolone on nuclear receptors in human endometrial cells. Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells
- Abstracts: Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Endometrial cancer in women 45 years of age or younger: A clinicopathological analysis
- Abstracts: Managed care does not lower costs but may result in poorer outcomes for patients with gestational diabetes. A dilated fetal stomach predicts a complicated postnatal course in cases of prenatally diagnosed gastroschisis
- Abstracts: Abnormal coronary vasoconstriction as a predictor of restenosis after successful coronary angioplasty in patients with unstable angina pectoris